PL2832359T3 - Krople do oczu zawierające diquafosol - Google Patents

Krople do oczu zawierające diquafosol

Info

Publication number
PL2832359T3
PL2832359T3 PL13770386T PL13770386T PL2832359T3 PL 2832359 T3 PL2832359 T3 PL 2832359T3 PL 13770386 T PL13770386 T PL 13770386T PL 13770386 T PL13770386 T PL 13770386T PL 2832359 T3 PL2832359 T3 PL 2832359T3
Authority
PL
Poland
Prior art keywords
diquafosol
eye drop
containing eye
drop
eye
Prior art date
Application number
PL13770386T
Other languages
English (en)
Inventor
Akiko SAKATANI
Tatsuo IKEI
Koji Inagaki
Masatsugu Nakamura
Kazuhiro Hosoi
Mikiko Saito
Masaki SONODA
Yoko Fukui
Mitsuaki Kuwano
Original Assignee
Santen Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49259901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2832359(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santen Pharma Co Ltd filed Critical Santen Pharma Co Ltd
Publication of PL2832359T3 publication Critical patent/PL2832359T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13770386T 2012-03-26 2013-03-25 Krople do oczu zawierające diquafosol PL2832359T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012069157 2012-03-26
EP13770386.4A EP2832359B1 (en) 2012-03-26 2013-03-25 Diquafosol-containing eye drop
PCT/JP2013/058519 WO2013146649A1 (ja) 2012-03-26 2013-03-25 ジクアホソル含有点眼液

Publications (1)

Publication Number Publication Date
PL2832359T3 true PL2832359T3 (pl) 2019-04-30

Family

ID=49259901

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13770386T PL2832359T3 (pl) 2012-03-26 2013-03-25 Krople do oczu zawierające diquafosol

Country Status (26)

Country Link
US (4) US9486529B2 (pl)
EP (2) EP2832359B1 (pl)
JP (6) JP5625081B2 (pl)
KR (5) KR101875845B1 (pl)
CN (2) CN104203254A (pl)
AU (3) AU2013241507A1 (pl)
BR (1) BR112014023402B1 (pl)
CA (1) CA2868390C (pl)
DK (1) DK2832359T3 (pl)
EA (1) EA028848B1 (pl)
ES (1) ES2702575T3 (pl)
GE (1) GEP20166470B (pl)
HK (1) HK1204922A1 (pl)
HU (1) HUE041671T2 (pl)
IN (1) IN2014DN08632A (pl)
MX (1) MX353874B (pl)
MY (1) MY169816A (pl)
NZ (1) NZ631041A (pl)
PH (1) PH12014501955B1 (pl)
PL (1) PL2832359T3 (pl)
PT (1) PT2832359T (pl)
SG (2) SG10201607872PA (pl)
TR (1) TR201820073T4 (pl)
TW (4) TWI625135B (pl)
UA (1) UA113981C2 (pl)
WO (1) WO2013146649A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2750229B2 (ja) 1991-05-30 1998-05-13 信越石英株式会社 大型軽量化反射鏡
JP2750234B2 (ja) 1991-12-25 1998-05-13 信越石英株式会社 シリカ質軽量反射鏡の製造方法
MY169816A (en) * 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
MX2016009049A (es) * 2014-01-10 2016-09-09 Santen Pharmaceutical Co Ltd Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico.
MX384935B (es) * 2014-12-25 2025-03-14 Santen Pharmaceutical Co Ltd Solucion oftalmica acuosa.
JP6104433B2 (ja) * 2015-06-05 2017-03-29 参天製薬株式会社 水性点眼液
HK1245651A1 (en) * 2015-06-05 2018-08-31 Santen Pharmaceutical Co., Ltd. Therapeutic agent for dry eye characterized by being to be dropped into eye of dry eye patient wearing soft contact lens
JPWO2017002827A1 (ja) 2015-06-29 2018-04-26 ヤマサ醤油株式会社 P1,p4−ビス(5’−ウリジル)テトラホスフェート結晶の保管方法
JP6688057B2 (ja) * 2015-12-01 2020-04-28 日水製薬株式会社 グラム染色用後染色試液及びグラム染色方法
KR102472773B1 (ko) * 2018-02-28 2022-11-30 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물
CN108403625A (zh) * 2018-04-11 2018-08-17 东莞解石医药科技有限公司 一种含有螯合剂的地夸磷索四钠滴眼液
WO2020046950A1 (en) * 2018-08-30 2020-03-05 Eyevance Pharmaceuticals Llc Ocular lubricant formulations
KR102656181B1 (ko) * 2019-08-27 2024-04-08 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
CN113720924B (zh) * 2020-05-25 2025-01-10 南京帝昌医药科技有限公司 一种地夸磷索四钠的含量及有关物质检测方法
JPWO2022107791A1 (pl) * 2020-11-18 2022-05-27
WO2022107790A1 (ja) * 2020-11-18 2022-05-27 参天製薬株式会社 アルキルジアミノエチルグリシンまたはその塩を含有する水性点眼液
KR102548710B1 (ko) 2020-12-24 2023-06-28 주식회사 종근당 디쿠아포솔 또는 이의 약제학적으로 허용가능한 염과 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물
CN112933040A (zh) * 2021-02-04 2021-06-11 合肥博思科创医药科技有限公司 一种舒更葡糖钠注射液的制备方法
WO2023195718A1 (ko) * 2022-04-04 2023-10-12 서울대학교산학협력단 감미 억제용 조성물 및 식품의 감미 억제 방법
KR102794468B1 (ko) * 2022-04-04 2025-04-14 서울대학교산학협력단 감미 억제용 조성물 및 식품의 감미 억제 방법
JP7735925B2 (ja) * 2022-05-02 2025-09-09 株式会社三洋物産 遊技機
CN116019767A (zh) * 2023-01-12 2023-04-28 上海阿尔福斯医药科技有限公司 眼用制剂及其制备方法
CN117838628B (zh) * 2024-03-01 2024-05-28 广州市桐晖药业有限公司 一种地夸磷索钠滴眼液及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075456B2 (ja) * 1988-10-01 1995-01-25 参天製薬株式会社 点眼液
JP2530491B2 (ja) 1988-12-20 1996-09-04 参天製薬株式会社 ヒアルロン酸点眼液
TW200402B (pl) 1990-08-13 1993-02-21 Senju Pharma Co
US5504113A (en) 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
US5900407A (en) 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
PT981534E (pt) 1997-02-06 2006-09-29 Inspire Pharmaceuticals Inc Dinucleotidos e suas utilizacoes
EP1012154B1 (en) 1997-07-25 2004-03-17 Inspire Pharmaceuticals, Inc. Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
KR19990074047A (ko) 1998-03-03 1999-10-05 김수복 콘택트렌즈용 세척, 소독 및 보존제 조성물
CN1133432C (zh) 1998-08-21 2004-01-07 千寿制药株式会社 含水液体药物组合物
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
JP4003008B2 (ja) * 2000-05-30 2007-11-07 参天製薬株式会社 角膜上皮伸展促進剤
KR100832821B1 (ko) * 2000-05-30 2008-05-28 산텐 세이야꾸 가부시키가이샤 각막 상피 신장 촉진제
US6555675B2 (en) * 2000-08-21 2003-04-29 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US6583181B1 (en) 2000-11-22 2003-06-24 Lonza Inc. Antimicrobial quaternary ammonium compositions with reduced ocular irritation
CN1228053C (zh) * 2001-09-11 2005-11-23 参天制药株式会社 含有二尿苷磷酸的滴眼液
JP2003160491A (ja) * 2001-09-11 2003-06-03 Santen Pharmaceut Co Ltd ジウリジンリン酸含有点眼液
WO2003030892A1 (en) 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
PT1468697E (pt) 2003-04-14 2008-03-05 Wyeth Corp Composições contendo piperacilina e tazobactam úteis para injecção
JP4806956B2 (ja) 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20060073172A1 (en) 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
CN101060846A (zh) 2004-12-02 2007-10-24 维纳斯药业有限公司 采用可用于注射的β-内酰胺酶抑制剂防止β-内酰胺酶介导抗生素抗性的成分
KR100870104B1 (ko) * 2005-11-28 2008-11-26 주식회사 머젠스 안구건조증 치료 및 예방용 조성물
JP4168071B2 (ja) 2005-12-08 2008-10-22 興和株式会社 点眼用組成物
JP2008247828A (ja) 2007-03-30 2008-10-16 Wakamoto Pharmaceut Co Ltd ラタノプロストを含有する水性医薬組成物。
JP2009040727A (ja) * 2007-08-09 2009-02-26 Towa Yakuhin Kk ラタノプロストを有効成分とする安定な点眼液剤
CN100534423C (zh) * 2007-11-30 2009-09-02 张咏梅 一种保质期长的氯霉素滴眼液及其制备方法
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
CN101461778A (zh) * 2009-01-06 2009-06-24 河北科技大学 不含抑菌剂的盐酸环丙沙星滴眼液及其制备方法
EP2393355A4 (en) * 2009-01-23 2012-07-25 Inspire Pharmaceuticals Inc METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN
CN102100693A (zh) * 2009-12-16 2011-06-22 沈阳兴齐制药有限公司 一种含有肌肽的人工泪液及其制备方法
KR20110104367A (ko) 2010-03-16 2011-09-22 삼천당제약주식회사 무보존제 안과용 조성물
MY173215A (en) 2010-07-21 2020-01-06 Cumberland Pharmaceuticals Inc Acetylcysteine compositions and methods of use thereof
PH12013500424B1 (en) 2010-09-10 2018-07-11 Santen Pharmaceutical Co Ltd Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
MY161032A (en) * 2010-12-28 2017-04-03 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
CN103596572A (zh) * 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
MY169816A (en) * 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
NZ631279A (en) 2012-03-26 2016-06-24 Dilafor Ab Method for treatment of labor arrest

Also Published As

Publication number Publication date
JP2017119718A (ja) 2017-07-06
KR101935484B1 (ko) 2019-01-04
JP6126041B2 (ja) 2017-05-10
HK1206648A1 (en) 2016-01-15
US20200215093A1 (en) 2020-07-09
JP7042762B2 (ja) 2022-03-28
EA028848B1 (ru) 2018-01-31
EP2832359B1 (en) 2018-11-14
US20170020910A1 (en) 2017-01-26
KR101536885B1 (ko) 2015-07-14
AU2016201111A1 (en) 2016-03-10
PH12014501955B1 (en) 2022-03-09
CA2868390C (en) 2020-03-31
AU2016201110A1 (en) 2016-03-10
EP2832359A1 (en) 2015-02-04
US20180353531A1 (en) 2018-12-13
KR20140136980A (ko) 2014-12-01
KR20190002751A (ko) 2019-01-08
KR20180079469A (ko) 2018-07-10
WO2013146649A1 (ja) 2013-10-03
PT2832359T (pt) 2019-01-29
CA2868390A1 (en) 2013-10-03
KR20200096708A (ko) 2020-08-12
TW202041220A (zh) 2020-11-16
NZ631041A (en) 2016-10-28
US10632139B2 (en) 2020-04-28
IN2014DN08632A (pl) 2015-05-22
US10071113B2 (en) 2018-09-11
AU2016201110B2 (en) 2017-06-15
US11166974B2 (en) 2021-11-09
US20150072951A1 (en) 2015-03-12
MX353874B (es) 2018-02-01
BR112014023402B1 (pt) 2020-09-29
TR201820073T4 (tr) 2019-01-21
JP6389544B2 (ja) 2018-09-12
SG11201405799TA (en) 2014-11-27
CN104203254A (zh) 2014-12-10
JP7447176B2 (ja) 2024-03-11
EP2832359A4 (en) 2015-03-25
GEP20166470B (en) 2016-04-25
JP5625081B2 (ja) 2014-11-12
SG10201607872PA (en) 2016-11-29
TWI625135B (zh) 2018-06-01
TWI757799B (zh) 2022-03-11
MX2014011468A (es) 2015-01-12
PH12014501955A1 (en) 2014-11-17
HK1204922A1 (zh) 2015-12-11
UA113981C2 (xx) 2017-04-10
CN113018259A (zh) 2021-06-25
HUE041671T2 (hu) 2019-05-28
JP2019070053A (ja) 2019-05-09
EA201491771A1 (ru) 2015-01-30
TW201343196A (zh) 2013-11-01
EP3431092A1 (en) 2019-01-23
TWI723722B (zh) 2021-04-01
AU2013241507A1 (en) 2014-10-09
JP6483299B2 (ja) 2019-03-13
JP2022075813A (ja) 2022-05-18
ES2702575T3 (es) 2019-03-04
TW202015704A (zh) 2020-05-01
TWI692364B (zh) 2020-05-01
JP2014132039A (ja) 2014-07-17
JP2018076384A (ja) 2018-05-17
KR101875845B1 (ko) 2018-07-06
TW201806583A (zh) 2018-03-01
MY169816A (en) 2019-05-16
JP2013227291A (ja) 2013-11-07
KR20150027312A (ko) 2015-03-11
US9486529B2 (en) 2016-11-08
DK2832359T3 (en) 2019-02-04

Similar Documents

Publication Publication Date Title
HUE041671T2 (hu) Diquafosolt tartalmazó szemcsepp
DK2830816T3 (en) Hidtil ukendt coatingkoncept
DK3327112T3 (en) Agse-deficient stamme
AU347441S (en) Eyeglasses
GB201403961D0 (en) No details
GB201304182D0 (en) No details
EP2935220A4 (en) PERI-carbinol
TWI563313B (en) Eyeglasses
GB201420527D0 (en) Electrical-wire-protecting member
GB201411220D0 (en) No details
GB201903206D0 (en) n
IL235925A0 (en) –o–3heteroaryl–inganol
GB2518076B (en) Electrical-wire-protecting member
SI2818180T1 (sl) Protivirusne kapljice za oko
GB201313844D0 (en) No details
GB201403415D0 (en) No details
GB201220061D0 (en) Four eyes
GB201121832D0 (en) B(eye)-focals
AU342356S (en) Sunglasses
AU342460S (en) Sunglasses
GB201219912D0 (en) Fly eye
GB201322955D0 (en) No details
GB201400108D0 (en) No details
GB201215711D0 (en) Higher
GB201302155D0 (en) No details